CVS Group (OTCMKTS:CVSGF – Get Free Report) is expected to post its resultson Thursday, September 24th. Analysts expect CVS Group to announce earnings of $0.6150 per share and revenue of $478.0470 million for the quarter.
CVS Group Price Performance
CVS Group stock opened at $16.60 on Tuesday. CVS Group has a 52-week low of $14.50 and a 52-week high of $17.66. The firm has a fifty day moving average of $16.60 and a 200-day moving average of $16.52.
Analyst Ratings Changes
Separately, Barclays raised shares of CVS Group to an “overweight” rating in a research report on Friday, July 31st. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy”.
About CVS Group
CVS Group PLC operates as a leading provider of veterinary and pet care services in the United Kingdom, offering a comprehensive range of clinical and diagnostic solutions for companion and farm animals. Through its network of practices, the company delivers routine veterinary care, advanced surgical procedures, dental services and pet wellness programs. Its integrated model seeks to streamline care delivery by combining in‐house clinical teams with centralized support functions.
In addition to traditional veterinary services, CVS Group maintains a dedicated specialist business that includes emergency and referral practices, as well as mobile clinical units.
Recommended Stories
- Five stocks we like better than CVS Group
- Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?
- Coach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback
- AI Is Reshaping SaaS—These 2 Software ETFs Offer Different Ways to Play It
- Insiders Signal Deep Value In DICK’s Sporting Goods
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
